Clinical Trial: Prediction of Immunotherapy Prognosis and Screening of Beneficial Populations in Advanced Hepatocellular Carcinoma Using Multimodal Models Integrating Radiomics and Deep Learning (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prediction of Immunotherapy Prognosis and Screening of Beneficial Populations in Advanced Hepatocellular Carcinoma Using Multimodal Models Integrating Radiomics and Deep Learning'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131035

Registration Time: 2026/08/27

Type: Diagnostic test

Primary Sponsor: Southern Medical University Southern Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337752

Published by HT Digital Content Services with permission from Health Daily Digest....